| Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers. M Ismail, S Botros, A Metwally, S William, A Farghally, LF Tao, TA Day, ... The American journal of tropical medicine and hygiene 60 (6), 932-935, 1999 | 580 | 1999 |
| Are poor responses to praziquantel for the treatment of Schistosoma mansoni infections in Senegal due to resistance? An overview of the evidence B Gryseels, A Mbaye, SJ De Vlas, FF Stelma, F Guisse, L Van Lieshout, ... Tropical medicine & international health 6 (11), 864-873, 2001 | 265 | 2001 |
| Praziquantel: its use in control of schistosomiasis in sub-Saharan Africa and current research needs MJ Doenhoff, P Hagan, D Cioli, V Southgate, L Pica-Mattoccia, S Botros, ... Parasitology 136 (13), 1825-1835, 2009 | 244 | 2009 |
| Determination of ED50 values for praziquantel in praziquantel-resistant and-susceptible Schistosoma mansoni isolates D Cioli, SS Botros, K Wheatcroft-Francklow, A Mbaye, V Southgate, ... International journal for parasitology 34 (8), 979-987, 2004 | 162 | 2004 |
| Current status of sensitivity to praziquantel in a focus of potential drug resistance in Egypt S Botros, H Sayed, N Amer, M El-Ghannam, JL Bennett, TA Day International Journal for Parasitology 35 (7), 787-791, 2005 | 158 | 2005 |
| Praziquantel resistance SS Botros, JL Bennett Expert opinion on drug discovery 2 (sup1), S35-S40, 2007 | 125 | 2007 |
| Praziquantel-induced tegumental damage in vitro is diminished in schistosomes derived from praziquantel-resistant infections S William, S Botros, M Ismail, A Farghally, TA Day, JL Bennett Parasitology 122 (1), 63-66, 2001 | 113 | 2001 |
| Stability and reproductive fitness of Schistosoma mansoni isolates with decreased sensitivity to praziquantel S William, A Sabra, F Ramzy, M Mousa, Z Demerdash, JL Bennett, ... International journal for parasitology 31 (10), 1093-1100, 2001 | 96 | 2001 |
| MCR synthesis of praziquantel derivatives H Liu, S William, E Herdtweck, S Botros, A Dömling Chemical biology & drug design 79 (4), 470-477, 2012 | 95 | 2012 |
| Chemical Profiling of Polyphenolics in Eucalyptus globulus and Evaluation of Its Hepato–Renal Protective Potential Against Cyclophosphamide Induced Toxicity in … MA Ghareeb, M Sobeh, WH El-Maadawy, HS Mohammed, H Khalil, ... Antioxidants 8 (9), 415, 2019 | 77 | 2019 |
| Lack of evidence for an antischistosomal activity of myrrh in experimental animals S Botros, S William, F Ebeid, D Cioli, N Katz, TA Day, JL Bennett The American journal of tropical medicine and hygiene 71 (2), 206-210, 2004 | 77 | 2004 |
| Analysis of pan-African Centres of excellence in health innovation highlights opportunities and challenges for local innovation and financing in the continent S Nwaka, A Ochem, D Besson, B Ramirez, F Fakorede, S Botros, ... BMC international health and human rights 12, 1-15, 2012 | 69 | 2012 |
| Effect of praziquantel on the immature stages of Schistosoma haematobium S Botros, L Pica-Mattoccia, S William, N El-Lakkani, D Cioli International journal for parasitology 35 (13), 1453-1457, 2005 | 69 | 2005 |
| Efficacy of Mirazid in comparison with Praziquantel in Egyptian Schistosoma mansoni–infected school children and households S Botros, H Sayed, H El-Dusoki, H Sabry, I Rabie, M El-Ghannam, ... The American journal of tropical medicine and hygiene 72 (2), 119-123, 2005 | 67 | 2005 |
| Activity of 9-(S)-[3-Hydroxy-2-(Phosphonomethoxy)Propyl]Adenine against Schistosomiasis mansoni in Mice S Botros, S William, O Hammam, Z Zídek, A Holý Antimicrobial agents and chemotherapy 47 (12), 3853-3858, 2003 | 54 | 2003 |
| Metabolic profile and hepatoprotective activity of the anthocyanin-rich extract of Hibiscus sabdariffa calyces SM Ezzat, MM Salama, SH Seif el-Din, S Saleh, NM El-Lakkany, ... Pharmaceutical biology 54 (12), 3172-3181, 2016 | 52 | 2016 |
| Antipyrine clearance in comparison to conventional liver function tests in hepatitis C virus patients M Mahmoud, R Abdel-Kader, M Hassanein, S Saleh, S Botros European journal of pharmacology 569 (3), 222-227, 2007 | 51 | 2007 |
| Efficacy and safety of artemether in the treatment of chronic fascioliasis in Egypt: exploratory phase-2 trials J Keiser, H Sayed, M El-Ghanam, H Sabry, S Anani, A El-Wakeel, C Hatz, ... PLoS neglected tropical diseases 5 (9), e1285, 2011 | 47 | 2011 |
| Antifibrotic effects of gallic acid on hepatic stellate cells: In vitro and in vivo mechanistic study NM El-Lakkany, WH El-Maadawy, SHS El-Din, S Saleh, MM Safar, ... Journal of traditional and complementary medicine 9 (1), 45-53, 2019 | 42 | 2019 |
| Immunohistopathological and biochemical changes in Schistosoma mansoni-infected mice treated with artemether SS Botros, MR Mahmoud, MM Moussa, MM Nosseir Journal of Infection 55 (5), 470-477, 2007 | 42 | 2007 |
Naglaa M. El-LakkanyProfessor and Head of pharmacology Dept., Theodor Bilharz Research Instituteכתובת אימייל מאומתת בדומיין tbri.gov.eg